AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,779 | +153.7% | 801 | 0.0% | 0.01% | +133.3% |
| Q4 2022 | $3,460 | -42.3% | 801 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $6,000 | -25.0% | 801 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $8,000 | -20.0% | 801 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $10,000 | -44.4% | 801 | 0.0% | 0.01% | +600.0% |
| Q4 2021 | $18,000 | 0.0% | 801 | 0.0% | 0.00% | -94.4% |
| Q3 2021 | $18,000 | +80.0% | 801 | 0.0% | 0.02% | +125.0% |
| Q2 2021 | $10,000 | 0.0% | 801 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $10,000 | -9.1% | 801 | 0.0% | 0.01% | +11.1% |
| Q4 2020 | $11,000 | -8.3% | 801 | 0.0% | 0.01% | -35.7% |
| Q3 2020 | $12,000 | -7.7% | 801 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $13,000 | +8.3% | 801 | 0.0% | 0.02% | +14.3% |
| Q1 2020 | $12,000 | -25.0% | 801 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $16,000 | – | 801 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |